Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Kazuo Inada"'
Autor:
Tomoshi Tsuchiya, Ryotaro Kamohara, Masashi Muraoka, Takeshi Nagayasu, Sho Saeki, Mitsuhiro Takenoyama, Makoto Suzuki, Kazuo Inada, Shoji Tokunaga, Tomayoshi Hayashi, Shogo Urabe, Takaomi Koga, Shinji Akamine, Kenji Sugio
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-8 (2020)
Abstract Background Lymphovascular invasion (LVI), which includes vascular or lymphatic invasions, is a representative prognostic factor even in patients with resected stage IA non-small cell lung cancer (NSCLC). Because tegafur-uracil is effective o
Externí odkaz:
https://doaj.org/article/6f5c1773999b475b844c5c01eaf8e53c
Autor:
Ryo Mori, Shin-ichi Yamashita, Kensuke Midorikawa, Sosei Abe, Kazuo Inada, Satoshi Yoneda, Kan Okabayashi, Kazuki Nabeshima
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 14 (2020)
Background and Aim: Pulmonary large cell neuroendocrine carcinoma (LCNEC) is a rare neoplasm, and its clinical features and management are still limited. We evaluated the clinicopathological factors, including CDX2 immunohistochemical expression, to
Externí odkaz:
https://doaj.org/article/2a72f546ba0949338a75e391dfaf1797
Autor:
Ryotaro Kamohara, Kazuo Inada, Mitsuhiro Takenoyama, Takeshi Nagayasu, Sho Saeki, Kenji Sugio, Tomoshi Tsuchiya, Masashi Muraoka, Takaomi Koga, Makoto Suzuki, Shoji Tokunaga, Shinji Akamine, Tomayoshi Hayashi, Shogo Urabe
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-8 (2020)
BMC Cancer
BMC Cancer
Background Lymphovascular invasion (LVI), which includes vascular or lymphatic invasions, is a representative prognostic factor even in patients with resected stage IA non-small cell lung cancer (NSCLC). Because tegafur-uracil is effective on cancers
Publikováno v:
The Journal of the Japanese Association for Chest Surgery. 32:504-511
Autor:
Kensuke Midorikawa, Satoshi Yoneda, Shin-ichi Yamashita, Sosei Abe, Kazuo Inada, Kazuki Nabeshima, Kan Okabayashi, Ryo Mori
Publikováno v:
Clinical Medicine Insights. Oncology
Clinical Medicine Insights: Oncology, Vol 14 (2020)
Clinical Medicine Insights: Oncology, Vol 14 (2020)
Background and Aim:Pulmonary large cell neuroendocrine carcinoma (LCNEC) is a rare neoplasm, and its clinical features and management are still limited. We evaluated the clinicopathological factors, including CDX2 immunohistochemical expression, to p
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 75:821-825
Autor:
Kazuo Inada, Akinori Iwasaki
Publikováno v:
The Journal of the Japanese Association for Chest Surgery. 28:128-131
Autor:
Kazuo Inada, Akinori Iwasaki
Publikováno v:
The Journal of the Japanese Association for Chest Surgery. 28:668-675
Autor:
Takayuki Kanemaru, Nobuhiro Kodama, Kazutaka Hirota, Kazuo Inada, Shunji Kawamoto, Ryosuke Shibata, Taruhisa Yoshida
Publikováno v:
The Japanese Journal of Gastroenterological Surgery. 42:36-42
Autor:
Kazuo Inada, Takayuki Kanemaru, Shuji Nagao, Reiji Kaieda, Kiyohisa Uchida, Shunji Kawamoto, Takahiro Nakazato, Ryoji Ochiai
Publikováno v:
Japanese Journal of Transfusion and Cell Therapy. 54:31-37
(背景)輸血を受け入れないエホバの証人の患者に対する治療の対応や指針が検討され,現在に至っている.(目的)患者の意思決定を尊重する原則に立って治療を推進していく上で,